- At its special meeting, Flex Pharma (NASDAQ:FLKS) stockholders voted in favor of all merger-related proposals associated with its planned tie-up with Salarius Pharmaceuticals announced in January. The transaction should close in the coming weeks
- The combined company will do business as Salarius Pharmaceuticals.
- Shares are up 15% after hours.
Date: 22/07/2019
Source : seekingalpha